Skip to main content

POLYGENIC HYPERCHOLESTEROLEMIA

Tracking # 20-1057358

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

HYPERCHOLESTEROLEMIA CAUSES ATHEROSCLEROTIC VASCULAR DISEASE LEADING TO THE DEVELOPMENT OF CORONARY ARTERY DISEASE, TRANSIENT ISCHEMIC ATTACK, STROKE, AND PERIPHERAL ARTERY DISEASE. POLYGENIC HYPERCHOLESTEROLEMIA IS A FAMILIAL CONDITION WHERE THERE IS AN ELEVATION IN SERUM CHOLESTEROL LEVELS DUE TO MUTATION IN SEVERAL SMALL LDL RAISING ALLELES. THE MUTATION IS DETECTED USING 12 SINGLE NUCLEOTIDE POLYMORPHISMS (SNP) SCORE. POLYGENIC HYPERCHOLESTEROLEMIA IS ASYMPTOMATIC AND IS DETECTED DURING ROUTINE SCREENING. PRIMARY CARE PHYSICIANS AND CARDIOLOGISTS PLAY AN IMPORTANT ROLE IN EVALUATING AND TREATING PATIENTS TO REDUCE COMPLICATIONS OF THE DISEASE. THE ACTIVITY DESCRIBES THE EVALUATION AND TREATMENT OF POLYGENIC HYPERCHOLESTEROLEMIA BY PRIMARY CARE PHYSICIANS (PCPS) AND CARDIOLOGISTS.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I